摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6,2'-dimethoxyflavanone | 6344-22-5

中文名称
——
中文别名
——
英文名称
6,2'-dimethoxyflavanone
英文别名
6-methoxy-2-(2-methoxy-phenyl)-chroman-4-one;6-Methoxy-2-(2-methoxy-phenyl)-chroman-4-on;6-Methoxy-2-(2-methoxyphenyl)-2,3-dihydro-4H-chromen-4-one;6-methoxy-2-(2-methoxyphenyl)-2,3-dihydrochromen-4-one
6,2'-dimethoxyflavanone化学式
CAS
6344-22-5
化学式
C17H16O4
mdl
——
分子量
284.312
InChiKey
NJGRSFDTFXJJSG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    120 °C
  • 沸点:
    446.4±45.0 °C(Predicted)
  • 密度:
    1.204±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    21
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.24
  • 拓扑面积:
    44.8
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    盐酸胡椒醛6,2'-dimethoxyflavanone 生成 alkaline earth salt of/the/ methylsulfuric acid
    参考文献:
    名称:
    Katschalowsky; v. Kostanecki, Chemische Berichte, 1904, vol. 37, p. 3171
    摘要:
    DOI:
  • 作为产物:
    描述:
    2'-hydroxy-2,5'-dimethoxychalconedisodium hydrogenphosphate 作用下, 以 乙醇 为溶剂, 反应 36.0h, 以84%的产率得到6,2'-dimethoxyflavanone
    参考文献:
    名称:
    5′-Chloro-2,2′-dihydroxychalcone and related flavanoids as treatments for prostate cancer
    摘要:
    Several flavonoids and their biosynthetic precursor chalcones were designed and synthesized to improve the biological effects of the lead compound 2'-hydroxyflavonone against androgen receptor (AR)-dependent transcriptional stimulation. Newly synthesized chalcones 19 and 26 suppressed AR dependent transcription as well as DHT-dependent growth stimulation at a low micromolar level. These compounds were also effective against ligand-independent constitutively active mutant AR derived from castration-resistant PCa (CRPC). Compounds 19 and 26 showed broad spectrum anti-proliferative activity at 5-10 mu M against multiple tumor cell lines including androgen-independent and taxane-resistant prostate cancer as well as a multidrug-resistant subline. Mode of action studies suggested that 19 induced sub-G1 accumulation in PC-3 cells by disrupting the microtubule network without affecting cell cycle progression. Furthermore, the in vivo effectiveness of chalcone 19 was confirmed in a xenograft model antitumor assay. Thus, chalcone 19 has the potential to be a bifunctional lead for treatment of AR-dependent PCa at lower doses as well as AR-independent PCa, including CRPC, at higher doses. (C) 2018 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2018.08.069
点击查看最新优质反应信息

文献信息

  • Katschalowsky; v. Kostanecki, Chemische Berichte, 1904, vol. 37, p. 2348
    作者:Katschalowsky、v. Kostanecki
    DOI:——
    日期:——
  • Vyas; Shah, Journal of the Indian Chemical Society, 1951, vol. 28, p. 75,78
    作者:Vyas、Shah
    DOI:——
    日期:——
  • 5′-Chloro-2,2′-dihydroxychalcone and related flavanoids as treatments for prostate cancer
    作者:Yohei Saito、Atsushi Mizokami、Hiroyuki Tsurimoto、Kouji Izumi、Masuo Goto、Kyoko Nakagawa-Goto
    DOI:10.1016/j.ejmech.2018.08.069
    日期:2018.9
    Several flavonoids and their biosynthetic precursor chalcones were designed and synthesized to improve the biological effects of the lead compound 2'-hydroxyflavonone against androgen receptor (AR)-dependent transcriptional stimulation. Newly synthesized chalcones 19 and 26 suppressed AR dependent transcription as well as DHT-dependent growth stimulation at a low micromolar level. These compounds were also effective against ligand-independent constitutively active mutant AR derived from castration-resistant PCa (CRPC). Compounds 19 and 26 showed broad spectrum anti-proliferative activity at 5-10 mu M against multiple tumor cell lines including androgen-independent and taxane-resistant prostate cancer as well as a multidrug-resistant subline. Mode of action studies suggested that 19 induced sub-G1 accumulation in PC-3 cells by disrupting the microtubule network without affecting cell cycle progression. Furthermore, the in vivo effectiveness of chalcone 19 was confirmed in a xenograft model antitumor assay. Thus, chalcone 19 has the potential to be a bifunctional lead for treatment of AR-dependent PCa at lower doses as well as AR-independent PCa, including CRPC, at higher doses. (C) 2018 Elsevier Masson SAS. All rights reserved.
  • Katschalowsky; v. Kostanecki, Chemische Berichte, 1904, vol. 37, p. 3171
    作者:Katschalowsky、v. Kostanecki
    DOI:——
    日期:——
查看更多